Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipoproteinemias

Clinical trial condition

Hyperlipoproteinemias

Explore clinical trials studying Hyperlipoproteinemias. Study availability and eligibility vary by location and protocol.

231 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipoproteinemias trial results

Completed

Screening for Hypercholesterolemia in Children Using Dried Blood Spot

NCT05191355

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Hospices Civils de Lyon, Dept of Endocrinology Bron, France

Hospices Civils de Lyon, Service d'Hépatologie et de Gastro-Entérologie et Nutrition Pédiatrique Bron, France

View Trial Details

Completed

A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia

NCT04031742

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Beijing Anzhen Hospital, Capital Medical University Beijing, China

View Trial Details

Completed

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

NCT04849000

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +11 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, China

View Trial Details

Completed

Universal Familial Hypercholesterolemia Screening in Children

NCT04507984

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations: Children's Hospital AUF DER BULT Hanover, Germany

UMC - University Children's Hospital Ljubljana Ljubljana, Slovenia

View Trial Details

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH

NCT04034485

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: NorthShore University Health System Evanston, Illinois, United States

Metabolic & Atherosclerosis Research Center (MARC) Cincinnati, Ohio, United States

VMMC & Safdarjung Hospital Delhi, National Capital Territory of Delhi, India

CIMS Hospital Pvt. Ltd Ahmedabad, India

View Trial Details

Completed

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

NCT03060577

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations: Novartis Investigative Site Jacksonville, Florida, United States

Novartis Investigative Site Indianapolis, Indiana, United States

Novartis Investigative Site New York, United States

Novartis Investigative Site Cincinnati, Ohio, United States

View all 52 locations

View Trial Details

Completed

Coronary and Heart Effects of Early Treatment in Familial Hypercholesterolemia

NCT05352386

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Amsterdam UMC, location AMC Amsterdam, Netherlands

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

NCT03933293

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

Beijing Anzhen Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Orlistat for the Treatment of Type I Hyperlipoproteinemia

NCT02767531

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas, Texas, United States

View Trial Details

Completed

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

NCT03851705

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: (50852-001) Queen Mary Hospital Hong Kong

(50972-001) Hadassah Hospital Lipid Research Ein Kerem Jerusalem, Israel

(50007-001) Research Institute of Complex Issues of Cardiovascular Diseases Kemerovo, Russia

(50007-003) National Medical Research Centre of Cardiology Moscow, Russia

View all 13 locations

View Trial Details